title: Using risk factors for detection and prognostication of uveal melanoma.
abstract: The early detection of malignancy, particularly uveal melanoma, is crucial in protecting visual acuity, salvaging the eye, and preventing metastasis. Risk factors for early detection of uveal melanoma have been clearly delineated in the literature and allow identification of melanoma when it is tiny and simulates a nevus. These factors include thickness >2 mm, presence of subretinal fluid (SRF), symptoms, the orange pigment, margin near optic disc, acoustic hollowness, surrounding halo, and absence of drusen. The importance of early detection is realized when one considers melanoma thickness, as each millimeter increase in melanoma thickness imparts 5% increased risk for metastatic disease. Newer imaging modalities like enhanced depth imaging optical coherence tomography and fundus autoflouroscence facilitate in detection of SRF and orange pigment. Additional molecular biomarkers and cytological features have been identified which can predict the clinical behavior of a small melanocytic lesion. Features that suggest a poor prognosis include higher blood levels of tyrosinase m-RNA, vascular endothelial growth factor, insulin-like growth factor; monosomy 3 and gains in chromosome 8. Management of uveal melanoma includes enucleation (for large), local eye wall resection, brachytherapy, charged particle irradiation, and thermotherapy (for small to medium tumors). Although the role of a good clinical evaluation cannot be underestimated, it is advisable to evaluate the various radiological, molecular, and cytological features, to enhance the accuracy of early diagnosis and improved prognosis.
authors.affiliation: Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India.
authors.forename: Pukhraj
authors.initials: P
authors.lastname: Rishi
authors.forename: Vikram V
authors.initials: VV
authors.lastname: Koundanya
authors.forename: Carol L
authors.initials: CL
authors.lastname: Shields
mesh_terms: D020022:Genetic Predisposition to Disease; D014943:Global Health; D006801:Humans; D008545:Melanoma / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics; D009017:Morbidity / Q000639:trends; D009367:Neoplasm Staging / Q000379:methods*; D011379:Prognosis; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D015996:Survival Rate / Q000639:trends; D014604:Uveal Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics; D000098943:Uveal Melanoma
references.citation: Br J Ophthalmol. 2007 Oct;91(10):1299-302
references.pmid: 17431017
references.citation: Ophthalmology. 1980 Jun;87(6):523-8
references.pmid: 7413141
references.citation: Arch Ophthalmol. 2006 Oct;124(10):1428-34
references.pmid: 17030710
references.citation: Ophthalmology. 2002 Aug;109(8):1553-60
references.pmid: 12153810
references.citation: Clin Cancer Res. 2002 Feb;8(2):534-9
references.pmid: 11839674
references.citation: Arch Ophthalmol. 1997 Dec;115(12):1537-44
references.pmid: 9400787
references.citation: Arch Ophthalmol. 1996 Aug;114(8):956-63
references.pmid: 8694731
references.citation: Arch Ophthalmol. 1992 Feb;110(2):245-50
references.pmid: 1531290
references.citation: Arch Ophthalmol. 2009 Aug;127(8):989-98
references.pmid: 19667335
references.citation: Ophthalmology. 2000 Aug;107(8):1443-9
references.pmid: 10919885
references.citation: Br J Cancer. 2009 Sep 1;101(5):813-5
references.pmid: 19654573
references.citation: Arch Ophthalmol. 2006 Jan;124(1):54-60
references.pmid: 16401785
references.citation: N Engl J Med. 2010 Dec 2;363(23):2191-9
references.pmid: 21083380
references.citation: Eye (Lond). 2012 Sep;26(9):1157-72
references.pmid: 22744385
references.citation: Am J Ophthalmol. 1977 Mar;83(3):299-323
references.pmid: 848534
references.citation: Br J Ophthalmol. 2008 May;92(5):617-22
references.pmid: 18441171
references.citation: Arch Ophthalmol. 2000 Mar;118(3):360-4
references.pmid: 10721958
references.citation: Eye (Lond). 2009 Dec;23(12):2152-60; quiz 2161-2
references.pmid: 19876071
references.citation: Am J Ophthalmol. 1979 Apr;87(4):480-6
references.pmid: 443311
references.citation: Ophthalmology. 2007 Oct;114(10):1925-31
references.pmid: 17719643
references.citation: Curr Eye Res. 2010 Sep;35(9):857-63
references.pmid: 20795869
references.citation: Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4372-5
references.pmid: 16303922
references.citation: Histopathology. 2004 Jul;45(1):1-12
references.pmid: 15228438
references.citation: Future Oncol. 2008 Oct;4(5):629-36
references.pmid: 18922120
references.citation: JAMA Ophthalmol. 2013 Aug;131(8):993-1003
references.pmid: 23681424
references.citation: Curr Eye Res. 2007 Mar;32(3):281-90
references.pmid: 17453948
references.citation: Ophthalmology. 2011 Feb;118(2):396-401
references.pmid: 20869116
references.citation: Ophthalmology. 1995 Sep;102(9):1351-61
references.pmid: 9097773
references.citation: Ophthalmology. 1984 Jun;91(6):685-91
references.pmid: 6462627
references.citation: Am J Ophthalmol. 1998 Jun;125(6):745-66
references.pmid: 9645714
references.citation: Br J Ophthalmol. 1983 Sep;67(9):575-8
references.pmid: 6882712
references.citation: Br J Ophthalmol. 1978 Jun;62(6):420-5
references.pmid: 352389
references.citation: Invest Ophthalmol Vis Sci. 2002 Jan;43(1):1-8
references.pmid: 11773005
references.citation: Br J Ophthalmol. 2000 Jul;84(7):750-6
references.pmid: 10873988
references.citation: Clin Cancer Res. 2008 Feb 15;14(4):951-6
references.pmid: 18281525
references.citation: Retina. 2013 Oct;33(9):1763-76
references.pmid: 23584696
references.citation: J Skin Cancer. 2011;2011:573974
references.pmid: 21773036
references.citation: Invest Ophthalmol Vis Sci. 2010 May;51(5):2329-37
references.pmid: 20042655
references.citation: Am J Ophthalmol. 1983 Oct;96(4):502-9
references.pmid: 6624832
references.citation: Melanoma Res. 2010 Aug;20(4):303-10
references.pmid: 20442676
references.citation: Ophthalmology. 2008 Aug;115(8):1390-7, 1397.e1-2
references.pmid: 18267342
references.citation: Lancet. 1996 May 4;347(9010):1222-5
references.pmid: 8622452
references.citation: Arch Ophthalmol. 2012 Jul;130(7):850-6
references.pmid: 22776921
references.citation: Surv Ophthalmol. 2004 Jul-Aug;49(4):419-28
references.pmid: 15231397
references.citation: Arch Ophthalmol. 2007 Aug;125(8):1017-24
references.pmid: 17698747
references.citation: Ophthalmology. 2008 Mar;115(3):546-552.e2
references.pmid: 18067966
references.citation: Eye (Lond). 2009 Mar;23(3):497-503
references.pmid: 18670456
references.citation: Arch Ophthalmol. 2009 Aug;127(8):981-7
references.pmid: 19667334